Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves hair follicles shrinking, influenced by hormones like melatonin and prolactin.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

People with both obvious and not-so-obvious underactive thyroid issues often have higher levels of the hormone prolactin.

Most men seeking hair transplants have Male Pattern Baldness, influenced by genetics, age, and testosterone, while women's hair loss can be affected by thyroid function, iron, testosterone, prolactin, ferritin levels, and certain conditions. Follicular Unit Extraction is a popular hair transplant technique.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Using neurohormones to control keratin can lead to new skin disease treatments.

Melatonin implants affect the growth and pattern of cashmere goat fleece depending on the time of year they are given.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Hair growth and health are influenced by stress and hormones.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.